Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study Phase II INSIGHT 2 study now open for enrollment for patients with locally advanced or metastatic non-small …

source https://finance.yahoo.com/news/updated-results-investigational-therapy-tepotinib-120000160.html?.tsrc=rss